171 related articles for article (PubMed ID: 10412281)
21. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
22. Examining the utility of in-clinic "rescue" therapy for acute migraine.
Morey V; Rothrock JF
Headache; 2008 Jun; 48(6):939-43. PubMed ID: 18549372
[TBL] [Abstract][Full Text] [Related]
23. [Satisfaction and recovery of normal activity with rizatriptan 10 mg. Results from the open, prospective, observational 4M study].
Mateos V; Roig C; López Rodríguez I; López-Gil A
Neurologia; 2002 Dec; 17(10):621-7. PubMed ID: 12487957
[TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
25. Migraine headache: review of parameters, etiology, and intervention.
Adams HE; Feuerstein M; Fowler JL
Psychol Bull; 1980 Mar; 87(2):217-37. PubMed ID: 7375599
[No Abstract] [Full Text] [Related]
26. Migraine-related vertigo: diagnostic criteria and prophylactic treatment.
Maione A
Laryngoscope; 2006 Oct; 116(10):1782-6. PubMed ID: 17003732
[TBL] [Abstract][Full Text] [Related]
27. Biofeedback treatment for headache disorders: a comprehensive efficacy review.
Nestoriuc Y; Martin A; Rief W; Andrasik F
Appl Psychophysiol Biofeedback; 2008 Sep; 33(3):125-40. PubMed ID: 18726688
[TBL] [Abstract][Full Text] [Related]
28. Rational combination therapy in refractory migraine.
Peterlin BL; Calhoun AH; Siegel S; Mathew NT
Headache; 2008 Jun; 48(6):805-19. PubMed ID: 18549358
[TBL] [Abstract][Full Text] [Related]
29. [Acupuncture at points of the liver and gallbladder meridians for treatment of migraine: a multi-center randomized and controlled study].
Zhong GW; Li W; Luo YH; Wang SE; Wu QM; Zhou B; Chen JJ; Liu BL
Zhongguo Zhen Jiu; 2009 Apr; 29(4):259-63. PubMed ID: 19565729
[TBL] [Abstract][Full Text] [Related]
30. [Drug treatment of migraine in children: state of the art].
Cuvellier JC; Joriot S; Auvin S; Vallée L
Arch Pediatr; 2004 May; 11(5):449-55. PubMed ID: 15135430
[TBL] [Abstract][Full Text] [Related]
31. Randomized trial vs. observational study of acupuncture for migraine found that patient characteristics differed but outcomes were similar.
Linde K; Streng A; Hoppe A; Weidenhammer W; Wagenpfeil S; Melchart D
J Clin Epidemiol; 2007 Mar; 60(3):280-7. PubMed ID: 17292022
[TBL] [Abstract][Full Text] [Related]
32. Spontaneous vertigo and headache: endolymphatic hydrops or migraine?
Boismier TE; Disher MJ
Ear Nose Throat J; 2001 Dec; 80(12):881-5. PubMed ID: 11775522
[TBL] [Abstract][Full Text] [Related]
33. Aerobic exercise with relaxation: influence on pain and psychological well-being in female migraine patients.
Dittrich SM; Günther V; Franz G; Burtscher M; Holzner B; Kopp M
Clin J Sport Med; 2008 Jul; 18(4):363-5. PubMed ID: 18614890
[TBL] [Abstract][Full Text] [Related]
34. Behavioral medicine for migraine.
Buse DC; Andrasik F
Neurol Clin; 2009 May; 27(2):445-65. PubMed ID: 19289225
[TBL] [Abstract][Full Text] [Related]
35. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Headache; 2005; 45(7):874-82. PubMed ID: 15985104
[TBL] [Abstract][Full Text] [Related]
36. Use of a structured migraine diary improves patient and physician communication about migraine disability and treatment outcomes.
Baos V; Ester F; Castellanos A; Nocea G; Caloto MT; Gerth WC;
Int J Clin Pract; 2005 Mar; 59(3):281-6. PubMed ID: 15857323
[TBL] [Abstract][Full Text] [Related]
37. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
[TBL] [Abstract][Full Text] [Related]
38. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
[TBL] [Abstract][Full Text] [Related]
39. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
Aurora SK; Rozen TD; Kori SH; Shrewsbury SB
Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249
[TBL] [Abstract][Full Text] [Related]
40. Is the Migraid device an asset in the non-pharmacologic treatment of migraine?
Pieterse H; Kuster JA; Van Bortel LM
Acta Neurol Belg; 2007 Jun; 107(2):40-6. PubMed ID: 17710839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
